mc2-25
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2022 (NCT05853471)
Timeline
Indications
Mechanism of action
- Unspecified target
isocyanate scavenger
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06132919 | Phase 2 | Oct 11, 2023 | MC2 Therapeutics |
| NCT05618119 | N/A | Jan 1, 2023 | University of Groningen |
| NCT05482698 | Phase 2 | Jul 1, 2022 | MC2 Therapeutics |
| NCT05853471 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2022 | University of Groningen |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MC2 Therapeutics | For profit | 2 | 2 | 1 | 2022 |
| University of Groningen | Academic/Hospital | 2 | 2 | 2 | 2022 |
2 organizations
Page 1 / 1